September 4, 2017 – The Stem Cell Foundation

Mesenchymal Stem Cells Increase Hippocampal Neurogenesis and Neuronal Differentiation by Enhancing the Wnt Signaling Pathway in an Alzheimer’s Disease Model

Post author:2by2host
Post published:September 4, 2017
Post category:Articles Stem Cells

Neurogenesis in the subgranular zone of the hippocampal dentate gyrus may act as an endogenous repair mechanism in Alzheimer’s disease (AD), and the Wnt signaling pathway has been suggested to…

Mesenchymal Stem Cells as a Treatment for Peripheral Arterial Disease: Current Status and Potential Impact of Type II Diabetes on Their Therapeutic Efficacy

Post author:2by2host
Post published:September 4, 2017
Post category:Articles Stem Cells

Mesenchymal stem cells (MSCs), due to their paracrine, transdifferentiation, and immunosuppressive effects, hold great promise as a therapy for peripheral arterial disease. Diabetes is an important risk factor for peripheral…

Preserved β-Cell Function in Type 1 Diabetes by Mesenchymal Stromal Cells

Post author:2by2host
Post published:September 4, 2017
Post category:Articles

The retention of endogenous insulin secretion in type 1 diabetes is an attractive clinical goal, which opens possibilities for long-term restoration of glucose metabolism. Mesenchymal stromal cells (MSCs) constitute, based…

Human mesenchymal stem cells alter the gene profile of monocytes from patients with Type 2 diabetes and end-stage renal disease

Post author:2by2host
Post published:September 4, 2017
Post category:Articles Stem Cells

Aim: Macrophage infiltration contributes to the pathogenesis of Type 2 diabetes. Mesenchymal stem cells (MSCs) possess immunomodulatory properties, making them an ideal candidate for therapeutic intervention. This study investigated whether MSCs…